Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Homepage
Tags search
Biosimilars

CTech 24/7

17:12 Navan to file confidentially for IPO, betting on market reopening
16:13 Israel delivers economic decapitation strike on Iranian regime
10:57 Israeli Mossad established combat drone bases on Iranian soil
07:05 Israel strikes Iran's nuclear sites and military commanders in major attack

Biosimilars

2 stories about Biosimilars

Teva Is Pulling an Ace From its Sleeve in its Attempt to Reinvent Itself
11.11.19|Uri Tal-TeneWith one anti-cancer biosimilar launching this week and another expected to hit the market soon, Teva could be creating a new growth engine worth hundreds of millions of dollars a year
Copaxone Profit will Continue to Fall, But Teva is Set to Double Down on Biosimilars
08.01.19|Lilach Baumer and Hezi SternlichtSpeaking at J.P. Morgan’s Healthcare Conference on Monday, CEO Kåre Schultz said he expects the U.S. generic market to stabilize in 2019

Twitter

Facebook

Rss

About CTech Terms of Use Privacy Policy

CTech 24/7

Biosimilars

Teva Is Pulling an Ace From its Sleeve in its Attempt to Reinvent Itself

Copaxone Profit will Continue to Fall, But Teva is Set to Double Down on Biosimilars